A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects
Clinical trial NCT04793204 · COMPLETED
Trial details
- NCT number
- NCT04793204
- Sponsor
- Astellas Pharma China, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-24
- Primary completion
- 2021-05-21
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.